search icon
prph-img

ProPhase Labs Inc, Common Stock

PRPH

NAQ

$0.6055

-$0.04

(-6.16%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$14.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
237.40K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.10
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.56 L
$7.48 H
$0.6055

About ProPhase Labs Inc, Common Stock

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FramePRPHSectorS&P500
1-Week Return-15.34%0.31%-1.26%
1-Month Return-11.73%0.6%-4.16%
3-Month Return-74.77%-9.44%-0.46%
6-Month Return-81.2%-5.15%3.58%
1-Year Return-87.89%0.33%22.47%
3-Year Return-91.71%4.53%25.13%
5-Year Return-66.91%35.98%77.7%
10-Year Return-62.85%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue9.88M14.51M79.04M122.65M44.38M[{"date":"2019-12-31","value":8.05,"profit":true},{"date":"2020-12-31","value":11.83,"profit":true},{"date":"2021-12-31","value":64.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":36.19,"profit":true}]
Cost of Revenue7.26M9.91M46.23M51.99M28.14M[{"date":"2019-12-31","value":13.97,"profit":true},{"date":"2020-12-31","value":19.06,"profit":true},{"date":"2021-12-31","value":88.91,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.13,"profit":true}]
Gross Profit2.62M4.61M32.81M70.65M16.24M[{"date":"2019-12-31","value":3.7,"profit":true},{"date":"2020-12-31","value":6.52,"profit":true},{"date":"2021-12-31","value":46.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.98,"profit":true}]
Gross Margin26.48%31.73%41.51%57.61%36.59%[{"date":"2019-12-31","value":45.96,"profit":true},{"date":"2020-12-31","value":55.09,"profit":true},{"date":"2021-12-31","value":72.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.51,"profit":true}]
Operating Expenses5.85M8.59M23.01M47.06M37.85M[{"date":"2019-12-31","value":12.44,"profit":true},{"date":"2020-12-31","value":18.26,"profit":true},{"date":"2021-12-31","value":48.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.44,"profit":true}]
Operating Income(3.24M)(3.98M)9.80M23.59M(21.61M)[{"date":"2019-12-31","value":-13.73,"profit":false},{"date":"2020-12-31","value":-16.89,"profit":false},{"date":"2021-12-31","value":41.54,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-91.6,"profit":false}]
Total Non-Operating Income/Expense266.00K(454.00K)(5.00M)(1.30M)(2.03M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-170.68,"profit":false},{"date":"2021-12-31","value":-1880.45,"profit":false},{"date":"2022-12-31","value":-487.97,"profit":false},{"date":"2023-12-31","value":-762.41,"profit":false}]
Pre-Tax Income(3.11M)(2.33M)5.30M22.91M(22.80M)[{"date":"2019-12-31","value":-13.56,"profit":false},{"date":"2020-12-31","value":-10.15,"profit":false},{"date":"2021-12-31","value":23.16,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.53,"profit":false}]
Income Taxes(93.00K)94.00K(968.00K)4.45M(6.02M)[{"date":"2019-12-31","value":-2.09,"profit":false},{"date":"2020-12-31","value":2.11,"profit":true},{"date":"2021-12-31","value":-21.78,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-135.39,"profit":false}]
Income After Taxes(3.01M)(2.42M)6.27M18.46M(16.78M)[{"date":"2019-12-31","value":-16.32,"profit":false},{"date":"2020-12-31","value":-13.11,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-90.9,"profit":false}]
Income From Continuous Operations(3.11M)(2.33M)6.27M18.46M(10.47M)[{"date":"2019-12-31","value":-16.82,"profit":false},{"date":"2020-12-31","value":-12.6,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-56.74,"profit":false}]
Income From Discontinued Operations(40.00K)201.00K---[{"date":"2019-12-31","value":-19.9,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.01M)(2.42M)6.27M18.46M(16.78M)[{"date":"2019-12-31","value":-16.32,"profit":false},{"date":"2020-12-31","value":-13.11,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-90.9,"profit":false}]
EPS (Diluted)(0.28)(0.33)0.811.02(0.98)[{"date":"2019-12-31","value":-27.45,"profit":false},{"date":"2020-12-31","value":-32.35,"profit":false},{"date":"2021-12-31","value":79.41,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-96.08,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PRPH
Cash Ratio 0.02
Current Ratio 1.47
Quick Ratio 1.33

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PRPH
ROA (LTM) -22.98%
ROE (LTM) -50.92%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PRPH
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PRPH
Trailing PE NM
Forward PE 10.09
P/S (TTM) 0.86
P/B 0.41
Price/FCF NM
EV/R 3.50
EV/Ebitda 2.45
PEG NM

FAQs

What is ProPhase Labs Inc share price today?

ProPhase Labs Inc (PRPH) share price today is $0.6055

Can Indians buy ProPhase Labs Inc shares?

Yes, Indians can buy shares of ProPhase Labs Inc (PRPH) on Vested. To buy ProPhase Labs Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ProPhase Labs Inc be purchased?

Yes, you can purchase fractional shares of ProPhase Labs Inc (PRPH) via the Vested app. You can start investing in ProPhase Labs Inc (PRPH) with a minimum investment of $1.

How to invest in ProPhase Labs Inc shares from India?

You can invest in shares of ProPhase Labs Inc (PRPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in PRPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ProPhase Labs Inc shares
What is ProPhase Labs Inc 52-week high and low stock price?

The 52-week high price of ProPhase Labs Inc (PRPH) is $7.48. The 52-week low price of ProPhase Labs Inc (PRPH) is $0.56.

What is ProPhase Labs Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ProPhase Labs Inc (PRPH) is

What is ProPhase Labs Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ProPhase Labs Inc (PRPH) is 0.41

What is ProPhase Labs Inc dividend yield?

The dividend yield of ProPhase Labs Inc (PRPH) is 0.00%

What is the Market Cap of ProPhase Labs Inc?

The market capitalization of ProPhase Labs Inc (PRPH) is $14.46M

What is ProPhase Labs Inc’s stock symbol?

The stock symbol (or ticker) of ProPhase Labs Inc is PRPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top